bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

Cryo-­EM  structure  of  coronavirus-­HKU1  haemagglutinin  esterase  reveals  
architectural  changes  arising  from  prolonged  circulation  in  humans  
  
Daniel   L.   Hurdiss1,2*,   Ieva   Drulyte3#,   Yifei   Lang1#,   Tatiana   M.   Shamorkina4,   Matti   F.  
Pronker4,  Frank  J.M.  van  Kuppeveld  1,  Joost  Snijder4  &  Raoul  J.  de  Groot1*  
  
1

Department  of  Infectious  Diseases  and  Immunology,  Virology  Division,  Faculty  of  Veterinary  

Medicine,  Utrecht  University,  3584CL  Utrecht,  The  Netherlands.  
2

Cryo-­Electron  Microscopy,  Bijvoet  Center  for  Biomolecular  Research,  Department  of  Chemistry,  

Faculty  of  Science,  Utrecht  University,  Padualaan  8,  3584  CH  Utrecht,  The  Netherlands  
3

Materials  and  Structural  Analysis,  Thermo  Fisher  Scientific,  Eindhoven,  5651  GG,  The  Netherlands.  

4

Biomolecular  Mass  Spectrometry  and  Proteomics,  Bijvoet  Center  for  Biomolecular  Research,  

Department  of  Chemistry,  Faculty  of  Science,  Utrecht  University,  Padualaan  8,  3584  CH  Utrecht,  The  
Netherlands  

*Corresponding  authors:  d.l.hurdiss@uu.nl  and  r.j.degroot@uu.nl  
#

Equal  contribution  

  

  
  

  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

1  

Abstract  

2  

The   human   betacoronaviruses   HKU1   and   OC43   (subgenus   Embecovirus)   arose   from  

3  

separate  zoonotic  introductions,  OC43  relatively  recently  and  HKU1  apparently  much  longer  

4  

ago.   Embecovirus  particles  are   studded   with   two   types   of   surface  projections   called   S   (for  

5  

spike)   and   HE   (for   haemagglutinin-­esterase),   with   S   mediating   receptor-­binding   and  

6  

membrane  fusion  and  HE  acting  as  a  receptor-­destroying  enzyme.  Together,  they  promote  

7  

dynamic  virion  attachment  to  glycan-­based  receptors  with  9-­O-­acetylated  sialic  acid  as  main  

8  

constituent.   We   recently   showed   that   adaptation   of   HKU1   and   OC43   to   replication   in   the  

9  

human  respiratory  tract  involved  loss-­of-­function  mutations  in  the  lectin  domain  of  HE.  Here  

10  

we  present  the  cryo-­EM  structure  of  the  ~80  kDa,  heavily  glycosylated  HKU1  HE  at  a  global  

11  

resolution  of  3.4  Å.  Comparison  to  existing  HE  structures  reveals  a  drastically  truncated  lectin  

12  

domain,  incompatible  with  sialic  acid  binding,  but  with  the  structure  and  function  of  the  HE  

13  

esterase   domain   left   intact.  Our  cryo-­EM   structure,   in   combination   with   mass   spectrometry  

14  

analysis,  also  describes  the  extent  of  glycosylation  on  the  now  redundant  lectin  domain,  which  

15  

forms   a   putative   glycan   shield.   The   findings   further   our   insight   into   the   evolution   and   host  

16  

adaptation  of  human  embecoviruses  and  also  demonstrate  the  utility  of  cryo-­EM  for  studying  

17  

small,  heavily  glycosylated  proteins  which  are  intractable  to  X-­ray  crystallography.  
  

  
  

  
  

  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

18  

INTRODUCTION  

19  

Coronaviruses   (CoVs)   are   enveloped   positive-­sense   single-­stranded   RNA   viruses   of  

20  

mammals  and  birds  with  a  propensity  to  cross  host  species  barriers1.  Zoonotic  CoV  infections  

21  

pose  an  ever-­looming  threat  to  public  health2.  Indeed,  this  century  alone  saw  the  advent  of  

22  

three  novel  respiratory  CoVs  highly  lethal  to  humans.  The  2002/2003  SARS-­CoV  variant  was  

23  

quickly  contained3,4,  and  MERS-­CoV,  natural  to  dromedary  camels,  does  not  spread  efficiently  

24  

within   the   human   population5.   SARS-­CoV-­2,   however,   seems   well   on   course   to   become  

25  

established  in  humans6.  Four  other  respiratory  coronaviruses  of  zoonotic  origin  did  breach  the  

26  

species   barrier   successfully   and   are   maintained   worldwide   through   continuous   human-­to-­

27  

human  transmission7.  Studies  of  these  latter  human  CoVs  and  their  zoonotic  ancestors  are  

28  

instrumental  in  understanding  the  odds  and  risks  of  CoV  cross-­species  transmission  as  well  

29  

as  the  requirements  for  adaptation  to  the  human  host.    

30  

Human  CoVs  HKU1  and  OC43  (subgenus  Embecovirus,  genus  Betacoronavirus)  are  related  

31  

but   distinct8.   In   immunocompetent   individuals,   these   viruses   are   generally   associated   with  

32  

benign  common  colds,  but  may  cause  significant  morbidity  and  even  mortality  in  the  frail9,10.  

33  

They  entered  the  human  population  separately:  HKU1  several  hundred  years  ago  from  a  yet  

34  

unknown  animal  reservoir11,12,  whereas  OC43  entered  far  more  recently  (70-­120  years  ago),  

35  

apparently   from   a   bovine   coronavirus   (BCoV)   spill-­over13.   These   embecoviruses   use   9-­O-­

36  

acetylated  sialoglycans  (9-­O-­Ac-­Sia)  as  receptors  to  which  they  attach  in  a  highly  dynamic  

37  

fashion   with   fast   on   and   off   rates   via   fusion   spike   protein   S14.   A   second   type   of   envelope  

38  

protein   unique   to   embecoviruses,   called   the   haemagglutinin-­esterase   (HE),   serves   as   a  

39  

receptor-­destroying  enzyme8.    

40  

CoV  HEs  are  40-­50  kDa  type  I  membrane  glycoproteins  that  assemble  into  covalently-­linked  

41  

homodimers,   disulfide-­bonded   in   the   juxta-­membrane   region15.   In   HEs   of   animal  

42  

embecoviruses,  an  O-­Ac-­Sia-­binding   lectin  domain   (LD)   appended  to   the   esterase   domain  

43  

(ED)   upregulates   sialate-­O-­acetylesterase   activity   towards   multivalent   ligands   such   as   the  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

44  

densely   clustered   sialoglycans   on   mucins15-­17.   However,   OC43   and   HKU1,   subject   to  

45  

convergent  evolution,  lost  HE  lectin  function8.  Thus,  the  dynamics  of  virion-­glycan  interactions  

46  

were   altered,   and   virion-­mediated   receptor   destruction   was   restricted,   apparently   as   an  

47  

adaptation   to   replication   in   the   human   respiratory   tract.   For  OC43,   the   phylogenetic   record  

48  

shows   that   after   its   introduction   in   humans,   HE-­mediated   receptor   binding   was   selected  

49  

against  and  ultimately  lost  completely  through  progressive  accumulation  of  subtle  single  site  

50  

substitutions  in  LD.  In  HKU1,  HE  lectin  function  was  also  lost,  but  here  the  LD  suffered  several  

51  

deletions8,18.    

52  

For   OC43,   BCoV   and   murine   embecoviruses8,15-­17,   HE   crystal   apo-­   and   holostructures  

53  

revealed   how   HE   LDs   bind   O-­Ac-­Sias  and  how   this  property   was   lost   in   OC43.   HKU1   HE,  

54  

however,  proved  refractory  to  crystallisation.  Exhaustive  attempts  to  solve  its  structure  and  

55  

assess  the  structural  consequences  of  the  LD  deletions  did  not  meet  with  success,  prompting  

56  

us  to  consider  alternative  methods.  In  the  last  decade,  single-­particle  analysis  by  cryo-­electron  

57  

microscopy  (SPA  cryo-­EM)  revolutionised  the  field  of  structural  biology  with  methodological  

58  

advances   now   allowing   the   visualisation   of   large   biological   macromolecules   at   resolutions  

59  

which  permit  atomic  modelling19.  In  the  wake  of  these  innovations,  cryo-­EM  structures  were  

60  

determined  for  several  CoV  S  proteins,  including  those  of  OC43  and  HKU1  to  resolutions  of  

61  

2.8   and   4   Å   resolution,   respectively20,21.   These   studies   were   greatly   facilitated   by   the  

62  

considerable  size  (>400  kDa)  and  three-­fold  symmetry  of  the  S  homo-­trimers.  Because  of  the  

63  

low  signal-­to-­noise  ratio  of  cryo-­EM  images,  SPA  reconstruction  of  specimens  smaller  than  

64  

100  kDa  remains  problematic  and  only  for  a  handful  of  such  proteins,  high-­resolution  (i.e.  <3.5  

65  

Å)  cryo-­EM  structures  have  been  resolved22-­24.  Nevertheless,  inspired  by  these  reports,  we  

66  

explored   SPA   to   characterise   the   homo-­dimeric   HKU1   HE   ectodomain,   a   complex   with   a  

67  

protein  mass  of  ~80  kDa  plus  ~30  kDa  of  N-­glycans,  most  of  which  is  disordered.  Here  we  

68  

present  the  structure  of  HKU1  HE  at  a  global  resolution  of  3.4  Å.  The  data  reveal  that,  over  

69  

centuries  of  HKU1  circulation  in  humans,  the  variable  loops  that  form  the  LD  receptor-­binding  

70  

site  were  trimmed  back  completely.  The  jelly  roll  core  structure,  on  which  these  loops  were  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

71  

grafted,  remains  intact,  presumably  to  preserve  structure-­function  of  the  ED  SGNH  hydrolase  

72  

into   which   it   is   embedded.   Conceivably,   the   conservation   of   a   functionally   obsolete   but  

73  

structurally  essential  domain  in  a  viral  envelope  protein  may  pose  an  antigenic  liability.  The  

74  

data   show   that   through   acquisition   of   new   N-­linked   glycosylation   sites,   the   HKU1   HE   LD  

75  

domain  was  provided  with  a  putative  glycan  shield.  The  findings  provide  structural  insight  into  

76  

the  evolution  of  multidomain  proteins  after  partial  loss  of  function  and  a  predictive  evolutionary  

77  

trajectory  for  OC43  HE.    

  
78  

RESULTS  

79  

Structure  determination  of  HKU1  HE  by  single-­particle  analysis      

80  

There   are   two   variants   of   the   HKU1   HE   protein,   type   A   and   type   B,   which   share   ~85%  

81  

sequence  identity25.  For  structural  analysis,  the  HKU1-­A  HE  ectodomain  was  expressed  as  

82  

an   Fc   fusion   protein   in   HEK293T   cells   and   purified   by   protein   A   affinity   chromatography,  

83  

followed   by   on-­the-­bead   thrombin   cleavage   to   remove   the   Fc   domain,   and   size   exclusion  

84  

chromatography  (Figure  S1A).  The  protein  backbone  of  the  HKU1  HE  ectodomain  construct  

85  

has  a  molecular  weight  of  ~40  kDa  but  runs  as  a  smeared  band  between  50  and  75  kDa  by  

86  

SDS-­PAGE   analysis   (Figure   S1B),   indicating   extensive   and   heterogeneous   glycosylation.  

87  

Optimised  cryo-­EM  grids,  prepared  with  purified  HKU1  HE,  revealed  monodisperse  particles  

88  

in  a  variety  of  orientations  (Figure  1A).  Single-­particle  analysis  produced  2D  class  averages  

89  

corresponding   to   different   views   of   the   HKU   HE   dimer   (Figure   1B).   Subsequently,   a   3D  

90  

reconstruction  of  HKU1  HE  was  produced  at  a  global  resolution  of  3.4  Å  (Figure  1C,  S2  and  

91  

S3A-­B).  Local  resolution  of  the  map  ranges  from  3.3-­4.1  Å  with  the  most  well-­resolved  regions  

92  

located  in  the  core  of  the  molecule  (Figure  S3D).  The  quality  of  the  map  permitted  modelling  

93  

of   residues   15-­346   (Figure   1D-­E).   Each   protomer   is   stabilised   by   six   disulfide   bonds,   the  

94  

presence  of  which  are  corroborated  by  the  cryo-­EM  density  (Figure  1F).  Dimerisation  of  HKU1  

95  

HE  is  achieved  by  interaction  of  the  vestigial  LDs  and  the  membrane-­proximal  domains  (MP)  

96  

(Figure  2A-­B).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

  
Figure  1:  Structure  determination  of  HKU1  HE  by  single-­particle  analysis.  A)  Representative  
motion-­corrected   electron   micrograph   of   HKU1   HE   embedded   in   vitreous   ice.   B)  
Representative  reference-­free  2D  class  averages.  C)  Orthogonal  views  of  the  HKU1  HE  EM  
density  (coloured  by  subunit).  D)  Cartoon  representation  of  the  atomic  model  of  the  dimeric  
HKU1   HE   complex.   E)   EM   density   (blue   mesh)   zoned   2  Å   around   an   α-­helix   comprising  
residues   112–132.   F)   EM   density   (blue   mesh)   zoned   2  Å   around   a   β-­sheet   comprising  
residues  181-­188,  219-­224  and  243-­248.  
  

97  

Comparison  of  HKU1  HE  to  those  of  related  embecoviruses  

98  

The  overall  fold  of  HKU1  HE  is  like  those  of  related  embecoviruses,  murine  coronavirus  (MHV)  

99  

and   BCoV,   both   of   which   have   a   functional   lectin   domain   (Figure   2B-­D)15,17.   Indeed,  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

100  

comparison  of  the  membrane  proximal  domain  and  esterase  domain  of  HKU1  to  these  related  

101  

proteins  revealed  a  high-­level  of  structural  conservation,  with  the  aligned  Ca  positions  having  

102  

RMSD  values  of  0.81  Å  and  0.76  Å  for  MHV-­New-­Jersey  (NJ)  strain,  and  0.83  Å  and  0.84  Å  

103  

for  BCoV-­Mebus  strain.  While  the  core  fold  of  the  esterase  domain  is  similar  between  all  three  

104  

proteins,   the  α2  helix   of   HKU1   more   closely   resembles   that   of  BCoV15,   and   lacks  the   zinc  

105  

binding  site  found  in  MHV-­NJ17  forms  a  zinc  binding  site17.  The  ED  catalytic  site  of  HKU1  HE  

106  

is   most   similar   to   that   of   BCoV,   OC43   and   MHV-­DVIM   strain   (Figure   S4A-­B),   which   all  

107  

recognise   9-­O-­Ac-­Sia.   This   is   consistent   with   functional   data   showing   that   HKU1   HE  

108  

possesses  sialate-­9-­O-­acetylesterase  receptor  destroying  activity8.  In  contrast,  MHV-­NJ  HE  

109  

recognises   4-­O-­Ac-­Sia,   thus   rationalising   the   differences   observed   in   the   active   site  

110  

architecture17  (Figure  S4C).    

111  

The  lectin  domain  of  HKU1  HE  dramatically  differs  from  those  of  MHV-­NJ  and  BCoV.  The  LD  

112  

jelly  roll  core  is  essentially  conserved,  with  RMSD  values  of  0.95  Å  and  0.89  Å  for  BCoV  and  

113  

MHV-­NJ,   respectively.   However,   whereas   in  BCoV   HE   and   MHV  extensive   loops  emanate  

114  

from  this  jelly  roll  core  to  form  the  LD  carbohydrate-­binding  site  (CBS),  such  loops  are  either  

115  

much  shorter  or  absent  in  the  HKU1  HE  structure  (Figure  2E-­G).  As  compared  to  the  BCoV  

116  

and  MHV  HEs,  HKU1  HE  suffered  deletions  in  the  β5-­β6  loop,  the  β7-­β8  loop,  and  β9-­β10  

117  

loop  (β11-­β12  in  BCoV)  –  see  figure  2  and  S5.  The  long  β4-­β5  loop  has  undergone  a  minor  

118  

deletion  in  HKU1  HE  but  is  also  displaced  with  respect  to  that  of  BCoV  and  MHV  HE,  reaching  

119  

a  maximum  distance  of  10  Å    between  residues  144-­148.  In  BCoV  and  MHV  HE,  each  of  these  

120  

loops  participates  in  ligand/receptor  binding.  In  addition,  the  metal  binding  site  (MBS)  which  

121  

stabilizes  the  β11-­β12  CBS  loop  in  MHV  and  BCoV  (β13-­β14)  is  absent  in  HKU1  (Figure  2E-­

122  

G).  Two  of  the  three  metal  coordinating  sidechains,  present  in  BCoV  HE  (Figure  S6A),  are  

123  

partially   conserved   in   HKU1,   indicating   that   the   MBS   was   likely   present   in   the   ancestral  

124  

protein.   However,  the   critical   D220   site   in   BCoV  HE   falls   within   the   β7-­β8   loop   deletion   of  

125  

HKU1  HE  (Figure  S6B).    Thus,  HKU1  has  lost  all  essential  components  of  the  HE  CBS  and  

126  

the  LD  domain  has  been  stripped  back  essentially  to  the  jelly  roll  core.  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

  
Figure  2:  Comparison  of  HKU1  HE  to  related  embecoviruses.  A)  Linear  representation  of  HE  
domain   organisation.   The   membrane   proximal   domain   (MPD),   esterase   domain   (E)   and  
receptor  domain  (R)  are  coloured  red,  green  and  blue,  respectively.  Grey  segments  indicate  
the  signal-­  peptide  (SP)  and  transmembrane  (TM)  domain.  The  bracket  indicates  the  part  of  
the  protein  for  which  the  structure  of  HKU1  HE  was  solved.  B)  Ribbon  representation  of  the  
dimeric  HKU1  HE  (residues  15–346),  C)  MHV-­NJ  HE  (PDB  ID:  5JIL,  residues  20–388)  and  
BCoV-­Mebus   HE   (PDB   ID:   3CL5,   residues   19–376)   structures.   One   monomer   is   coloured  
grey,  the  other  by  domain  organisation  shown  in  (A).  Bound  4-­O-­acetylated  (MHV)  or  9-­O-­
acetylated  (BCoV)  sialic  acid  is  coloured  orange.  Sodium  (MHV)  and  potassium  (BCoV)  ions  
are  coloured  purple  and  zinc  is  grey.  E)  Expanded  view  of  the  region  corresponding  to  the  LD  
carbohydrate-­binding  site  (CBS)  in  HKU1  HE,  (F)  MHV,  and  (G)  BCoV.  
  

127  

Mapping  of  N-­linked  glycans  by  cryo-­EM  and  glycoproteomics    

128  

HKU1  HE  contains  eight  predicted  N-­linked  glycosylation  sites  which  are  strictly  conserved  

129  

between   all   HKU1   field   strains   studied   so   far.   To   better   characterise   the   occupancy   and  

130  

composition   of   each   of   these   N-­linked   glycosylation   sites,   we   performed   in-­depth  

131  

glycoproteomics  profiling  of  the  same  recombinant  HEK293T  cell  derived  material  used  for  

132  

cryo-­EM.  HKU1  HE  was  digested  in  parallel  with  trypsin,  chymotrypsin  and  alpha  lytic  protease  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

133  

and   analysed   by   reverse   phase   liquid   chromatography   coupled   with   tandem   mass  

134  

spectrometry.   We   used   electron   transfer   high-­energy   collision   dissociation   (EThcD)  

135  

fragmentation  for  the  identification  of  N-­linked  glycopeptides.  A  total  of  150  unique  glycoforms  

136  

were  identified  across  all  8  N-­linked  glycosylation  sites,  99  of  which  with  sufficient  signals  for  

137  

semi-­quantitative  analysis   (Table  S2).   As  expected   from   HEK293T   cell   derived   materials26,  

138  

glycosylation  was  predominantly  of  complex  type  and  very  heterogeneous,  ranging  from  8-­59  

139  

unique   glycoforms   identified   for   each   site   (Figure   3A).   For   sites   N145,   N168   and   N193,  

140  

situated  on  the  LD  loops  (Figure  3B),  we  also  detected  substantial  signals  for  the  unmodified  

141  

asparagines,  without  glycosylation.  Based  on  the  combined  signal  intensities  of  all  glycoforms,  

142  

we  found  that  the  occupancy  of  those  sites  is  approximately  81%  for  N145,  <2%  for  N168  and  

143  

44%  for  N193.  The  low  occupancy  of  N168  agrees  with  the  lack  of  density  observed  in  the  

144  

cryo-­EM  map  (Figure  3C).  Furthermore,  the  high  B-­factors  of  the  LD  loops  suggests  flexibility  

145  

in  this  region  (Figure  S3E),  which  explains  the  limited  density  for  N110,  despite  having  100%  

146  

occupancy.   With   the   exception   of   N168,  the   first   core   N-­acetyl   glucosamine   (GlcNAc)   was  

147  

modelled   for   each   of   the   LD   loop   glycans   (Figure   3C).   The   remaining   four   sites   are   fully  

148  

occupied  based  on  our  MS  data,  in  accordance  with  strong  densities  observed  in  the  cryo-­EM  

149  

map.  Indeed,  we  were  able  to  model  the  entire  Man3,GlcNAc2  core  for  N314  (Figure  3C).  Apart  

150  

from   differences   in   glycan   occupancy,   we   also   observed   marked   differences   in   glycan  

151  

composition.  Whereas  the  overall  pattern  is  dominated  by  complex  glycosylation,  sites  N83  

152  

and  N328  show  predominant  hybrid  and  high-­mannose  glycosylation,  respectively.  Sites  N110  

153  

and   N145,   which   contain   mostly   complex   glycans,   are   also   heavily   (core)   fucosylated   and  

154  

contain  higher  numbers  of  sialic  acids.  Whereas  glycosylation  varies  substantially  from  site-­

155  

to-­site,  and  is  very  heterogeneous,  we  did  identify  a  set  of  glycan  compositions  that  are  highly  

156  

abundant  and  shared  at  the  majority  of  sites,  as  listed  in  Supplementary  Table  S3.  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

  
Figure  3:  N-­glycosylation  of  HKU1  HE.  A)  Glycoproteomic  analysis  of  N-­linked  glycosylation  
in  HKU1  HE.  Top  panel  enumerates  the  total  of  unique  glycan  compositions  identified  per  site.  
Bottom   three   panels   show   semiquantitative   analyses   from   extracted   peak   areas   of   site-­
specific  N-­glycosylation  by  glycan  type  (non-­glycosylated,  high-­mannose,  hybrid,  or  complex),  
fucosylation,   and   sialylation.   A   full   overview   is   presented   in   Supplementary   Table   S2.   B)  
Surface  representation  of  the  dimeric  HKU1  HE  atomic  model,  with  modelled  N-­glycans  shown  
as  spheres  and  coloured  according  to  the  predominant  glycan  type  shown  in  panel  (A).  C)  EM  
density  (blue  mesh)  zoned  2  Å  around  each  of  the  modelled  N-­glycans  and  analagous  region  
for   N168.   The   occupancy   and   glycan   length   distribution   from   glycoproteomics   analysis   for  
each  site  is  shown  below.  
  

157  

Glycosylation  of  HKU1  HE  lectin  domain  

158  

Side-­by-­side  comparison  of  HKU1,  MHV-­NJ,  BCoV  and  OC43  reveals  that  HKU1  HE  lectin  

159  

domain  has  a  much  flatter  topography  (Figure  4A-­D).  In  addition  to  the  dramatically  altered  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

160  

LD   landscape,   HKU1   has   undergone   substantial   changes   in   the   pattern   of   N-­linked  

161  

glycosylation  in  this  region.  Interestingly,  the  N-­linked  glycan  present  at  the  LD  dimer  interface  

162  

in  MHV  (N241),  BCoV  (N236)  and  OC43  (N235)  is  lost  in  HKU1  (Figure  4E-­H).  Compared  to  

163  

BCoV  and  MHV,  the  HKU1  LD  has  four  new  N-­linked  glycosylation  sites:  N110,  N145,  N168  

164  

and  N193,  two  of  which  localise  to  the  remnants  of  the  elongated  β5-­β6  loop  and  β7-­β10  loop.  

165  

Interestingly,   OC43   has   independently   acquired   equivalently   positioned   N-­linked   glycans  

166  

(N114  and  N153)  in  two  of  the  four  HKU1  LD  sites.  When  viewed  in  the  context  of  the  dimeric  

167  

structure,  HKU1  appears  to  have  distributed  its  N-­linked  glycans  to  the  periphery  of  the  lectin  

168  

domain.    

    
Figure  4:  Comparison  of  HKU1  HE  lectin  domain  glycosylation  to  related  embecoviruses.  A)  
Ribbon  representation  of  the  monomeric  HE  of  HKU1,  B)  MHV-­NJ,  C)  BCoV  and  D)  OC43  
lectin  domain.  Each  lectin  domain  glycosylation  site  is  labelled  and  colour-­  coded  according  
to  equivalent  positioning  across  the  four  HEs  shown.  Modelled  N-­glycans  are  shown  as  sticks  
and  coloured  orange.  E)  Top  down  view  of  the  dimeric  HE  of  HKU1  HE,  F)  MHV  (PDB  ID:  
5JIL),  G)   BCoV   (PDB   ID:  3CL5)  and   H)   OC43   (PDB   ID:  5N11)   lectin   domain,   shown  as   a  
surface   representation.   Modelled   N-­glycans  are  shown   as  orange   spheres   and   labelled  as  
shown  in  A-­D.  
  

169  

In  an  attempt  to  understand  the  evolutionary  benefit  of  LD  loop  deletions  and  increased  N-­

170  

linked  glycosylation,  we  first  looked  at  the  sequence  conservation  of  BCoV  HE.  The  BCoV  LD  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

171  

exhibits   modest   sequence   variation   which   localises   primarily   to   the   prominent   β5-­β6   loop,  

172  

which  participates  in  9-­O-­Sia  binding  (Figure  5A).  In  contrast,  comparison  of  available  HKU1-­

173  

A  HE  sequences  reveals  little  sequence  variation  on  the  LD  (Figure  5B).  In  the  sharpened  

174  

cryo-­EM  map,  the  glycans  on  the  LD  are  not  visible  beyond  the  first  core  GlcNAc.  However,  

175  

mass  spectrometry  analysis  confirms  that  these  primarily  contain  complex  glycans,  comprising  

176  

between   9   to   16   saccharide   units.   To   understand   where   these   lesser-­ordered   regions   are  

177  

situated,  a  difference  map  of  the  N-­linked  glycans  was  generated  and  a  gaussian  filter  was  

178  

applied  in  order  to  highlight  low  resolution  features.  Interestingly,  density  for  the  disordered  

179  

portion  of  these  glycans  forms  a  crown  of  glycan  density,  which  encircles  the  LD  and  covers  

180  

much   of   its   surface   (Figure   5C).   Of   note,   density   belonging   to   the   N110   glycan   of   HKU1  

181  

overlaps  with  the  former  sialic  acid  binding  site.  Side-­by-­side  comparison  shows  that  the  LD  

182  

of  HKU1  is  ~8  Å  shorter  than  BCoV,  with  none  of  the  CBS  loop  remnants  protruding  above  

183  

the  glycan  crown  (Figure  5D-­F).  While  our  mass  spectrometry  data  reveals  that  the  N168  site  

184  

is  only  1.6  %  occupied,  we  do  observe  difference  density  which  extends  tangentially  from  this  

185  

site.  This  putative  N168  density  extends  over  the  entrance  to  the  esterase  domain  active  site  

186  

(Figure  5F).      

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

Figure  5:  Visualizing  the  glycan  crown  of  HKU1  HE  lectin  domain.  A)  Top  down  view  of  the  
dimeric  BCoV  HE  lectin  domain,  shown  as  a  surface  representation  and  coloured  according  
to  sequence  conservation  (75  sequences).  N-­glycosylation  sites  are  labelled  and,  if  modelled,  
shown  as  orange  spheres.  The  sialic  acid  binding  site  is  circled  and  esterase  active  site  is  
indicated  by  an  asterisk.  B)  Equivalent  view  as  shown  in  A  for  HKU1  HE  (28  sequences).  C)  
The  same  view  as  shown  in  B  overlaid  with  the  HKU1  HE  N-­glycan  EM  difference  density,  
coloured  orange.  D)  Side  view  of  BCoV  HE  and  (E-­F)  HKU1  HE,  depicted  as  in  A-­C.  The  most  
membrane  distal  region  of  BCoV  and  HKU1  HE  is  indicated  by  a  dashed  line.    
  

187  

Discussion  

188  

Coronaviruses  pose  a  constant  zoonotic  threat,  as  poignantly  illustrated  by  the  ongoing  SARS-­

189  

CoV-­2  pandemic6.  It  is  therefore  of  relevance  to  understand  how  they  cross  species  barriers  

190  

and  subsequently  adapt  to  their  new  hosts.  Viruses  in  the  subgenus  Embecovirus,  a  minor  

191  

clade  in  the  genus  Betacoronavirus,    seem  particularly  apt  at  crossing  species  barriers.  Two  

192  

of  its  members,  OC43  and  HKU1,  arose  from  separate  zoonotic  introductions  to  become  firmly  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

193  

established  human  pathogens12.  Their  adaptation  to  replication  in  the  human  respiratory  tract  

194  

selected  for  loss  of  HE-­mediated  receptor-­binding,  which  in  turn  downregulated  HE  receptor-­

195  

destroying  activity  with  consequences  for  dynamic  virion-­receptor  interactions.  In  OC43,  which  

196  

emerged   only   recently13,   HE   lectin   function   was   reduced   and   ultimately   lost   through  

197  

accumulation   of   single   site   mutations   in   LD8.   HKU1      likely   followed   a   similar   evolutionary  

198  

trajectory  early  upon  its  entry  into  the  human  population,  but  after  several  hundreds  of  years  

199  

of  circulation11,  the  HE  LD  underwent  far  more  consequential  structural  changes  as  revealed  

200  

here  by  our  cryo-­EM  analysis.  Its  overall  structure  is  still  highly  similar  to  that  of  other  CoV  

201  

HEs,  especially  in  the  ED.  Of  the  LD,  the  jelly  roll  core  remains  intact,  but  the  CBS  loops  are  

202  

almost   completely   gone   and,   concomitantly,   the   number   of   N-­linked   glycosylation   sites  

203  

increased.   The   data   suggest   that   during   HKU1   evolution,   the   LD   was   trimmed   back  

204  

substantially,  once  it  became  functionally  obsolete.  However,  the  core  structure  of  the  LD  and  

205  

the  integrity  of  its  fold  is  essential  for  the  correct  folding  and  function  of  the  esterase  domain  

206  

and  so  it  remains  a  functional  module.  The  findings  beg  the  question  as  to  why  the  CBS  loops  

207  

were  deleted.  One  possible  explanation  is  that  the  protruding  surface-­exposed  regions  of  the  

208  

LD,   once   they   lost   their   function   in   ligand   binding,   remained   an   antigenic   liability.   Indeed,  

209  

embecovirus   HEs   are   under   selective   pressure   of   the   humoral   immune   response,   as  

210  

antibodies   against   HE   neutralise   BCoV   and   OC43   infectivity   in   vitro   and   confer   protection  

211  

against  BCoV  in  vivo27-­30.  The  most  prominent  β5-­β6  LD  loop  of  BCoV  HE,  directly  involved  in  

212  

9-­O-­Ac-­Sia  binding15,  is  a  hotspot  for  sequence  variation  (Figure  5A),  but  apparently  remains  

213  

a  target  for  immune  selection  even  after  loss  of  function,  given  the  sequence  variation  in  this  

214  

loop  also  in  OC43  HEs  (Figure  S7).  Among  type  A  HEs  of  contemporary  HKU1  field  strains,  

215  

sequence  variation  in  the  LD  is  limited  (Figure  5B),  but  there  are  considerable  differences  in  

216  

the   remaining   surface   exposed   LD   regions   between   type   A   and   B   HEs   (Figure   S8A),  

217  

suggestive  of  immune  pressure,  at  least  on  the  timescale  of  genotype  A  and  B  divergence25,31.    

218  

Immune  evasion  might  also  explain,  at  least  in  part,  the  increase  in  N-­glycosylation  sites  in  

219  

the  HKU1  HE  LD  as  compared  to  HEs  that  retain  their  receptor-­binding  function.  There  are  

220  

eight  N-­glycosylation  sites  (Figure  S8B),  strictly  conserved  among  HKU1  HEs,  four  of  which  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

221  

encircle   the  LD.   Remarkably,  however,   the  LD   dimer   interface   glycan   conserved   in   BCoV,  

222  

MHV  and  OC43,  was  lost  in  HKU1  (Figure  4E-­H).  Conceivably,  this  dimer  interface  glycan  

223  

could  serve  a  structural  role  in  stabilizing  the  CBS  architecture,  no  longer  required  in  HKU1  

224  

HE.    

225  

There  are  several  possible  explanations  for  the  newly  acquired  N-­linked  glycans,  including  (i)  

226  

with   loss   of   the   hydrophilic   LD   loops  they   add  hydrophilicity   and   thereby  aid   folding   of  the  

227  

hydrophobic   core   (Figure   S9),   (ii)   they   form   a   glycan   shield,   and/or   (iii)   some   of   them  

228  

contributed  to  loss  of  receptor-­binding  function  early  on  in  HKU1  evolution.  With  respect  to  the  

229  

latter  option,  the  introduction  of  a  glycan  at  N110  would  predictably  have  sterically  hindered  

230  

receptor  binding  in  the  context  of  a  functional  LD,  as  its  calculated  difference  density  would  

231  

have   overlapped   with   the   9-­O-­Ac-­Sia   binding   site   (Figure   6A-­B).   Indeed,   in   OC43   HE,   the  

232  

introduction  of  a  glycosylation  site  at  residue  114  in  the  same  loop  was  one  of  four  mutations  

233  

acquired  early  after  viral  introduction  in  humans,  and  which  contributed  the  most  to  loss  of  

234  

CBS  affinity8  (Figure  6C).    

Figure   6:   Possible   early   events   leading   to   HKU1   HE’s   loss   of   lectin   domain   function.   A)  
Zoomed  in  view  of  the  former  LD  carbohydrate-­binding  site  (CBS)  in  HKU1.  (B)  Equivalent  
view   as   shown   in   A   for   BCoV   HE,   with   9-­O-­acetylated   sialic   acid   shown   as   a   stick  
representation  and  coloured  orange,  and  residue  114  coloured  cyan.  (C)  Equivalent  view  as  
shown  in  A  for  OC43  HE,  with  possible  sterically  hindering  N-­linked  glycans  shown  as  sticks  
and  coloured  cyan.  
  

235  

With  respect  to  the  glycans  as  a  shield  against  humoral  immunity,  the  HKU1  HE  glycan  crown  

236  

not  only  covers  much  of  the  LD,  but  also  appears  to  extend  outwards  over  the  esterase  active  

237  

site   entrance.   The   entrance   to   the   HE   esterase   domain   active   site   is   subject   to   sequence  

238  

variation  in  BCoV  (Figure  5A),  suggesting  that  this  part  of  HE  too  is  a  vulnerable  target  for  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

239  

humoral  immunity.  In  the  context  of  a  crowded  viral  envelope,  with  densely  packed  S  and  HE  

240  

proteins,  the  membrane  distal  glycan  crown  of  HKU1  HE  might  help  shield  the  regions  below  

241  

without  any  potential  loss  of  function  resulting  from  direct  glycosylation  of  the  ED  active  site  

242  

entrance.    

243  

Interestingly,  OC43  has  independently  acquired  two  N-­linked  glycans  in  equivalent  positions  

244  

to   HKU1.   Thus,  our   findings   for   HKU1  offer   a   glimpse   into   a   possible   future   for   OC43   HE.  

245  

During  circulation  of  OC43  in  the  last  70-­120  years,  the  HE  LD  underwent  structural  changes  

246  

which  were  deleterious  to  9-­O-­Ac-­Sia  binding,  while  remaining  largely  intact.  Over  a  longer  

247  

timespan  OC43  HE  may  well  follow  the  fate  of  its  HKU1  homologue,  however,  through  similar  

248  

deletions  of  the  surface-­exposed  loops  in  the  LD.  Conversely,  the  evolution  of  OC43  allows  

249  

informed  speculation  on  the  early  steps  in  HKU1’s  adaptation  to  humans.    

250  

From  a  general  evolutionary  perspective,  our  data  offers  insights  into  how  viruses  deal  with  a  

251  

structurally   integral  but  enzymatically   obsolete   component  of   multifunctional  proteins   in  the  

252  

face  of  relentless  immune  pressure.  Interestingly,  receptor  binding  site  loop  deletions  have  

253  

also  been  reported  for  H7N2  and  H9N2  avian  influenza  haemagglutinin  proteins,  and  in  the  

254  

latter   case   were   demonstrated   to   facilitate   immune   escape32,33.   In   both   cases,   sialic   acid  

255  

binding   was   retained  but   the   receptor  preference   was   altered.   Also   for  the   HIV-­1   envelope  

256  

glycoprotein,   susceptibility   to   neutralising   antibodies   is   countered   by   modulating   surface  

257  

exposure  and  glycosylation  pattern  of  the  variable  regions34.  Our  findings  reinforce  the  notion  

258  

that  for  embecoviruses,  the  HE,  in  addition  to  S,  should  be  considered  a  viable  candidate  for  

259  

vaccine   development.   Moreover,   the   highly   conserved   HE   esterase   active   site   offers   an  

260  

attractive  target  for  the  development  of  broad-­spectrum  antivirals  against  OC43  and  HKU1  as  

261  

well   as   against   novel   human   embecoviruses,   should   such   emerge   in   the   future.   By  

262  

demonstrating  that  cryo-­EM  can  be  used  to  study  CoV  HEs  at  high-­resolution,  we  expand  the  

263  

structural   biology   toolkit   for   future   research,   which   may   focus   on   antibody   or   inhibitor  

264  

complexes.    
  
  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

265  

Methods  

266  

Protein  expression  and  purification  

267  

The  human  codon-­optimised  sequence  for  HKU1  HE  (Q5MQD1)  was  cloned  into  a  pCD5-­T-­

268  

Fc  expression  plasmid15.  The  resulting  construct  encodes  a  chimeric  protein  comprising  of  the  

269  

HE   ectodomain   fused   to   the   human   IgG1   Fc   domain,   with   the   domains   separated   by   a  

270  

thrombin  cleavage  site.  The  HE-­Fc  was  produced  by  transient  expression  in  HEK293T  cells  

271  

and  purified  from  cell  culture  supernatants  by  protein  A  affinity  chromatography  followed  by  

272  

on-­bead   thrombin   cleavage   as   described   previously15.   Beads   were   pelleted,   and   the   HE  

273  

ectodomain  in  the  supernatant  was  concentrated  to  a  volume  of  ~150  µl  and  injected  on  a  

274  

Superdex200   increase   column   (GE   Healthcare)   pre-­equilibrated   in   10  mM   Tris   pH   8   and  

275  

50  mM   NaCl.   Monodisperse  dimeric   fractions   were   concentrated  to   a  final   concentration  of  

276  

4.0  mg/ml   (Figure   S1A).   Sample   purity   was   assessed   by   SDS   PAGE   gel   analysis   (Figure  

277  

S1B).  

278  

  
Cryo-­electron  microscopy  

279  

Three  μl  of  purified  HKU1  HE  (4  mg/ml)  was  dispensed  on  Quantifoil  R1.2/1.3  200-­mesh  grids  

280  

(Quantifoil  Micro  Tools  GmbH)  that  had  been  freshly  glow  discharged  for  30  seconds  at  20  

281  

mA  using  GloQube  Glow  Discharge  system  (Quorum  Technologies).  Grids  were  blotted  for  

282  

five   seconds   using   Whatman   No.   1   filter   paper   and   immediately   plunge-­frozen   into   liquid  

283  

ethane  cooled  by  liquid  nitrogen  using  a  Vitrobot  Mark  IV  plunger  (Thermo  Fisher  Scientific)  

284  

equilibrated   to   ~95%   relative   humidity,   4°C.   Movies   of   frozen-­hydrated   HKU1   HE   were  

285  

collected  using  Titan  Krios  G4  Cryo-­TEM  (Thermo  Fisher  Scientific)  operating  at  300  keV  and  

286  

equipped  with  a  Falcon  4  Direct  Electron  Detector  (Thermo  Fisher  Scientific).  All  cryo-­EM  data  

287  

were  acquired  using  the  EPU  2  software  (Thermo  Fisher  Scientific).  Microscope  was  aligned  

288  

to   produce   fringe-­free   imaging   (FFI)   allowing   five   acquisition   areas   within   a   hole   and  

289  

aberration-­free  image  shift  (AFIS)  was  used  to  acquire  images  from  up  to  21  holes  per  single  

290  

stage  move.  Movies  were  collected  in  electron  counting  mode  at  96,000x  corresponding  to  a  

291  

calibrated  pixel  size  of  0.805  Å/pix  over  a  defocus  range  of  -­1.0  to  -­2.5  μm.  6,029  movies  were  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

292  

collected  using  a  dose  rate  of  5  e-­/pix/sec  for  a  total  of  5.6  seconds  (207  ms  per  fraction,  27  

293  

fractions),  resulting  in  a  total  exposure  of  ~40  e-­/Å2  (1.5  e-­/Å2/fraction).  

294  

  
Image  processing  

295  

Collected  movie  stacks  were  manually  inspected  and  then  imported  in  Relion  version  3.0.1.35  

296  

Drift  and  gain  correction  were  performed  with  MotionCor236,  and  GCTF37  was  used  to  estimate  

297  

the  contrast  transfer  function  for  each  movie.  Movies  with  a  GCTF-­estimated  resolution  of  10  Å  

298  

or   worse   were   discarded.   One   thousand  particles   were  picked   manually   and   2D   classified.  

299  

The   resulting   classes   were   then   used   as   templates   for   autopicking   in   Relion,   resulting   in  

300  

936,260   particles.   Fourier   binned   (2   x   2)   particles   were   extracted   in   a   90   pixel   box   and  

301  

subjected  to  a  round  of  2D  classification  after  which  565,194  particles  were  retained.  Using  

302  

the   ‘molmap’   command   in   UCSF   chimera38,   the   HKU1   HE   homology   model   was   used   to  

303  

generate   a  40  Å   resolution   starting   model   for   3D   classification.  Particles   selected   from   2D  

304  

classification   were   subject   to   a   round   of   3D   classification   (with   C2   symmetry).   Particles  

305  

belonging  to  the  best  class  (119,717  particles)  were  re-­extracted  unbinned  in  a  320  pixel  box  

306  

to   ensure   delocalised   high-­resolution   information   was   not   excluded.   Subsequent   3D   auto-­

307  

refinement  (with  C2  symmetry)  and  post-­processing  yielded  a  map  with  a  resolution  of  3.79  Å.  

308  

Further  sub-­classification  attempts  did  not  lead  to  improvements  in  map  quality  or  resolution.  

309  

Per  particle  defocus  estimation  improved  the  resolution  to  3.73  Å.  Relion’s  Bayesian  polishing  

310  

procedure   was   then   performed   on   these   particles,   with   all   movie   frames   included,   which  

311  

produced  a  3.68  Å  map39.  Next,  particles  were  assigned  to  their  respective  AFIS  group  and  

312  

subject   to   beam-­tilt   refinement   which   further   improved   the   resolution   to   3.48   Å.   Data  

313  

processing  was  then  continued  in  Relion  version  3.1b40,  where  a  final  round  of  per-­particle  

314  

defocus  and  per-­micrograph  astigmatism  estimation  was  performed.  This  produced  a  3.39  Å  

315  

resolution   map,   based   on   the   gold-­standard   FSC  =  0.143   criterion.   A   negative   B-­factor   of  

316  

−122  Å2  was  applied  during  the  final  post-­processing  step.  Local  resolution  estimations  were  

317  

performed  using  Relion.  An  overview  of  the  data  processing  pipeline  is  shown  in  Figure  S2.  
  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

318  

Model  building  and  refinement  

319  

Initially,   a   homology   model   of   HKU1   HE   (uniprot   ID:   Q5MQD1)   was   generated   using   the  

320  

phyre2   server41.   Each   protomer   was   individually  fitted   in   EM   density   map   using   the   UCSF  

321  

Chimera  ‘fit  in  map’  tool38.  The  resulting  dimeric  model  was  then  edited  in  Coot  using  the  ‘real  

322  

space  refinement’,  carbohydrate  module  and  ‘sphere  refinement’  tools42,43.  Iterative  rounds  of  

323  

manual  fitting  in  Coot  and  real  space  refinement  in  Phenix44  were  carried  out  to  improve  non-­

324  

ideal   rotamers,   bond   angles   and   Ramachandran   outliers.   During   real   space   refinement,  

325  

secondary   structure   and   NCS   restraints   were   imposed.   Validation   was   carried   out   using  

326  

Molprobity   (general/protein;;   45)  and  Privateer46,47.   All  data   collection,   image  processing  and  

327  

refinement  information  can  be  found  in  Table  S1.  

328  

  
Analysis  and  visualisation  

329  

To  generate  a  difference  map  of  the  N-­linked  glycans,  cryo-­EM  density  within  3  Å  of  a  fitted  

330  

HKU1   HE   dimer,   encompassing   only   the   protein   component,   was   erased   using   the   UCSF  

331  

chimera  ‘color  zone’  tool.  The  remaining  density  was  then  gaussian  filtered  using  the  ‘volume  

332  

filter’   tool   in   UCSF   chimera38.   Multiple   sequence  aligments   of   BCoV,  OC43  and   HKU1   HE  

333  

were  generated  using  NCBI  BLAST  and  subsequently  plotted  onto  their  respective  structures  

334  

using  UCSF  Chimera.  Alignment  of  the  representative  HKU1  genotype  A  and  B  sequences  

335  

(Figure   S8)   was   generated   using   the   EMBL-­EBI   Clustal   Omega   programme48.   Surface  

336  

colouring  of  BCoV  and  HKU1  HE  using  the  Kyte-­Doolittle  hydrophobicity  scale  was  performed  

337  

in   UCSF   chimera.   RMSD   values   were   calculated   using   the   ‘MatchMaker’   tool   of   UCSF  

338  

Chimera   with   default   settings.   Figures   were   generated   using   UCSF   Chimera38,   UCSF  

339  

ChimeraX49  and  PyMOL  (The  PyMOL  Molecular  Graphics  System,  Version  2.0,  Schrödinger,  

340  

LLC).  

341  

  
Sample  preparation  for  glycoproteomics  analysis.  

342  

Nine  μg  of  CoV-­HKU1  HE  were  incubated  in  100mM  Tris  pH  8.5,  2%  sodium  deoxycholate,  

343  

10mM  tris(2-­carboxyethyl)phosphine,  and  40mM  iodoacetamide  at  95°C  for  ten  minutes  and  

344  

at  25°C  for  30  minutes  in  the  dark.  Denatured,  reduced  and  alkylated  CoV-­HKU1  HE  (3  μg)  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

345  

was  then  diluted  into  fresh  50mM  ammonium  bicarbonate  and  incubated  overnight  at  37°C  

346  

either  with  0.056  μg  of  trypsin  (Promega),  chymotrypsin  (Sigma  Aldrich)  or  alpha  lytic  protease  

347  

(Sigma).  Formic  acid  was  then  added  to  a  final  concentration  of  2%  and  the  samples  were  

348  

centrifuged  at  14,000  rpm  for  20  min  at  4°C,  followed  by  another  round  of  centrifugation  for  5  

349  

min  to  precipitate  the  sodium  deoxycholate  and  collect  the  peptides  from  the  supernatants.  

350  

Then,  the  CoV-­HKU1  HE  tryptic,  chymotryptic  and  alpha  lytic  protease  digests  were  desalted  

351  

using  30  µm  Oasis  HLB  96-­well  plate  (Waters).  The  Oasis  HLB  sorbent  was  activated  with  

352  

100%  acetonitrile  and  subsequently  equilibrated  with  10%  formic  acid  in  water.  Next,  peptides  

353  

were  bound  to  the  sorbent,  washed  twice  with  10%  formic  acid  in  water  and  eluted  with  100  

354  

µL   of   50%   acetonitrile/5%formic   acid   (v/v).   The   eluted   peptides   were   vacuum-­dried   and  

355  

resuspended  in  100  µL  of  2%  formic  acid  in  water.    

356  

  
Mass  spectrometry  

357  

Six   μl   of   resuspended   peptides   for   the   glycoform   identification   and   two   μl   two-­fold   diluted  

358  

peptides  for  the  glycoform  quantification  were  run  on  an  Orbitrap  Fusion  Tribrid  (ThermoFisher  

359  

Scientific,  Bremen)   mass   spectrometer   coupled  to  nanospray   UHPLC   system  Agilent  1290  

360  

(Agilent  Technologies)  in  duplicates.  A  90-­min  LC  gradient  from  0%  to  35%  acetonitrile  was  

361  

used  to  separate  peptides  at  a  flow  rate  of  300  nl/min.  A  Poroshell  120  EC  C18  (50  cm  x  75  

362  

µm,  2.7  µm,  Agilent  Technologies)  analytical  column  and  a  ReproSil-­Pur  C18  (2  cm  x  100  µm,  

363  

3  µm,  Dr.  Maisch)  trap  column  were  used  for  the  peptide  separation.  The  data  was  acquired  

364  

in  data-­dependent  mode.  Orbitrap  Fusion  parameters  for  the  full  scan  MS  spectra  were  as  

365  

follows:  an  AGC  target  of  4∗10^5  at  60  000  resolution,  scan  range  350-­2000  m/z,  Orbitrap  

366  

maximum   injection   time   50   ms.   Ten   most   intense   ions   (2+   to   8+   ions)   were   subjected   to  

367  

fragmentation   with   electron-­transfer/higher   energy   collision   dissociation   ion   fragmentation  

368  

scheme50.  The  supplemental  higher  energy  collision  dissociation  energy  was  set  at  30%.  The  

369  

MS2  spectra  were  acquired  at  a  resolution  of  30  000  with  an  AGC  target  of  5∗10^5,  maximum  

370  

injection  time  250  ms,  scan  range  120-­4000  m/z  and  dynamic  exclusion  of  16  s.  
  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

371  

Mass  spectrometry  data  analysis  

372  

The  acquired  data  was  analysed  using  Byonic51  against  a  custom  database  of  recombinant  

373  

CoV-­HKU1  HE  protein  and  used  proteases,  searching  for  glycan  modifications  with  12/24  ppm  

374  

search   windows   for   MS1/MS2,   respectively.   Up   to   three   missed   cleavages   were  permitted  

375  

using   C-­terminal   cleavage   at   R/K   for   trypsin,   F/Y/W/M/L   for   chymotrypsin   and   T/A/S/V   for  

376  

alpha   lytic   protease.   Carbamidomethylation   of   cysteine   was   set   as   fixed   modification,  

377  

methionine   oxidation   as   variable   common   1,   glycan   modifications   as   variable   common   2,  

378  

allowing   up   to   max.   2   variable   common   parameters   per   one   peptide.   All   N-­linked   glycan  

379  

databases   from   Byonic   were   merged   into  a   single   non-­redundant   list   to  be   included   in  the  

380  

database  search.  All  reported  glycopeptides  in  the  Byonic  result  files  were  manually  inspected  

381  

for  quality  of  fragment  assignments.  All  glycopeptide  identifications  were  merged  into  a  single  

382  

non-­redundant  list  per  sequon.  Glycans  were  classified  based  on  HexNAc  content  as  high-­

383  

mannose  (2  HexNAc),  hybrid  (3  HexNAc)  or  complex  (>  3  HexNAc).  Byonic  search  results  

384  

were  exported  to  mzIdentML  format  to  build  a  spectral  library  in  Skyline   52  and  extract  peak  

385  

areas  for  individual  glycoforms  from  MS1  scans.  The  full  database  of  variable  N-­linked  glycan  

386  

modifications   from   Byonic   was   manually   added   to   the   Skyline   project   file   in   XML   format.  

387  

Reported  peak  areas  were  pooled  based  on  the  number  of  HexNAc,  Fuc  or  NeuAc  residues  

388  

to   distinguish   high-­mannose/hybrid/complex   glycosylation,   fucosylation   and   sialylation,  

389  

respectively.  The  quantified  data  was  represented  with  GraphPad  Prism  8  software.  
  

390  

Data  availability  

391  

Coordinates   are   deposited   in   the   Protein   Data   Bank   under   accession   code   6Y3Y.   The  

392  

corresponding  EM  density  maps  (final  unsharpened,  sharpened,  local  resolution  filtered,  half  

393  

maps,  N-­glycan  difference  map,  and  mask)  have  been  deposited  to  the  Electron  Microscopy  

394  

Data  Bank  under  the  accession  EMD-­10676.  The  raw  LC-­MS/MS  files  and  glycoproteomics  

395  

analyses  have  been  deposited  to  the  ProteomeXchange  Consortium  via  the  PRIDE  partner  

396  

repository  with  the  dataset  identifier  PXD017545.  All  reagents  and  relevant  data  are  available  

397  

from  the  authors  upon  request.  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

  

398  

Acknowledgements  

399  

D.L.H.  is  funded  from  the  European  Union’s  Horizon  2020  research  and  innovation  program  

400  

under  the  Marie  Skłodowska-­Curie  grant  agreement  (No  842333)  and  holds  an  EMBO  non-­

401  

stipendiary  long-­term  Fellowship  (ALTF  1172-­2018).  Research  reported  in  this  publication  was  

402  

supported  by  a  China  Scholarship  Council  grant  to  Y.L.  (No  2014-­03250042).  T.M.S.,  M.F.P  

403  

and  J.S.  are  supported  by  the  Dutch  Research  Council  NWO  Gravitation  2013  BOO,  Institute  

404  

for  Chemical  Immunology  (ICI,  024.002.009).  We  thank  Dr  Mihajlo  Vanevic  for  IT  support  and  

405  

Dr  Lingbo  Yu  for  her  assistance  processing  AFIS  data.    

406  

Author  contributions  

407  

D.L.H.,   Y.L.   and   R.J.G.   conceived   the   project.   Y.L.   generated   the   HKU1   HE   expression  

408  

construct  and  expressed  the  protein.  D.L.H.  and  Y.L.  performed  protein  purification.  T.M.S.  

409  

and  J.S.  performed  glycoproteomic  experiments  and  analysed  the  data.  I.D.  prepared  cryo-­

410  

EM   grids   and   set   up   data   collection.   D.L.H.   carried   out   single-­particle   image   processing.  

411  

D.L.H.  and  M.F.P.  built  and  analysed  the  structure.  D.L.H.,  J.S.,  F.J.M.K  and  R.J.G  supervised  

412  

the   project.   D.L.H.,   J.S.   and   R.J.G.   wrote   the   first   draft   and   all   authors   contributed   to   the  

413  

preparation  of  the  final  manuscript.  

414  

Competing  interests  

415  

The  authors  declare  no  competing  interests.  

416  

Corresponding  authors  

417  

Correspondence   to   Daniel   L.   Hurdiss   (d.l.hurdiss@uu.nl)   or   Raoul   J.   de   Groot  

418  

(r.j.degroot@uu.nl).  
  
  
  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  

  

  

References  
1.  

Geoghegan,  J.  L.,  Duchêne,  S.  &  Holmes,  E.  C.  Comparative  analysis  estimates  the  

relative   frequencies   of   co-­divergence   and   cross-­species   transmission   within   viral   families.  
PLoS  Pathog.  13,  e1006215  (2017).  
2.  

Menachery,   V.   D.  et  al.   A  SARS-­like  cluster   of   circulating   bat   coronaviruses   shows  

potential  for  human  emergence.  Nat.  Med.  21,  1508–1513  (2015).  
3.  

Drosten,   C.   et  al.   Identification  of  a  novel   coronavirus   in  patients   with   severe  acute  

respiratory  syndrome.  N.  Engl.  J.  Med.  348,  1967–1976  (2003).  
4.  

Ksiazek,   T.   G.   et   al.   A   novel   coronavirus   associated   with   severe   acute   respiratory  

syndrome.  N.  Engl.  J.  Med.  348,  1953–1966  (2003).  
5.  

Zaki,  A.  M.,  van  Boheemen,  S.,  Bestebroer,  T.  M.,  Osterhaus,  A.  D.  M.  E.  &  Fouchier,  

R.  A.  M.  Isolation  of  a  novel  coronavirus  from  a  man  with  pneumonia  in  Saudi  Arabia.  N.  Engl.  
J.  Med.  367,  1814–1820  (2012).  
6.  

Zhou,  P.  et  al.  A  pneumonia  outbreak  associated  with  a  new  coronavirus  of  probable  

bat  origin.  Nature  579,  270–273  (2020).  
7.  

Su,   S.   et   al.   Epidemiology,   Genetic   Recombination,   and   Pathogenesis   of  

Coronaviruses.  Trends  Microbiol.  24,  490–502  (2016).  
8.  

Bakkers,  M.  J.  G.  et  al.  Betacoronavirus  Adaptation  to  Humans  Involved  Progressive  

Loss  of  Hemagglutinin-­Esterase  Lectin  Activity.  Cell  Host  Microbe  21,  356–366  (2017).  
9.  

Morfopoulou,  S.  et  al.  Human  Coronavirus  OC43  Associated  with  Fatal  Encephalitis.  

https://doi.org/10.1056/NEJMc1509458  375,  497–498  (2016).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  
10.  

  

  

Woo,  P.  C.  Y.,  Lau,  S.  K.  P.  &  Yuen,  K.  Y.  Clinical  features  and  molecular  epidemiology  

of   coronavirus-­HKU1-­associated   community-­acquired   pneumonia.   Hong   Kong   Med   J   15  
Suppl  9,  46–47  (2009).  
11.  

Lau,  S.  K.  P.  et  al.  Discovery  of  a  novel  coronavirus,  China  Rattus  coronavirus  HKU24,  

from  Norway  rats  supports  the  murine  origin  of  Betacoronavirus  1  and  has  implications  for  the  
ancestor  of  Betacoronavirus  lineage  A.  Journal  of  Virology  89,  3076–3092  (2015).  
12.  

Cui,  J.,  Li,  F.  &  Shi,  Z.-­L.  Origin  and  evolution  of  pathogenic  coronaviruses.  Nat.  Rev.  

Microbiol.  17,  181–192  (2019).  
13.  

Vijgen,  L.  et  al.  Complete  genomic  sequence  of  human  coronavirus  OC43:  molecular  

clock  analysis  suggests  a  relatively  recent  zoonotic  coronavirus  transmission  event.  Journal  
of  Virology  79,  1595–1604  (2005).  
14.  

Hulswit,  R.  J.  G.  et  al.  Human  coronaviruses  OC43  and  HKU1  bind  to  9-­O-­acetylated  

sialic  acids  via  a  conserved  receptor-­binding  site  in  spike  protein  domain  A.  Proc.  Natl.  Acad.  
Sci.  U.S.A.  116,  2681–2690  (2019).  
15.  

Zeng,   Q.,   Langereis,   M.   A.,   van   Vliet,   A.   L.   W.,   Huizinga,   E.   G.   &   de   Groot,   R.   J.  

Structure  of  coronavirus  hemagglutinin-­esterase  offers  insight  into  corona  and  influenza  virus  
evolution.  Proc.  Natl.  Acad.  Sci.  U.S.A.  105,  9065–9069  (2008).  
16.  

Langereis,   M.   A.   et   al.   The   murine   coronavirus   hemagglutinin-­esterase   receptor-­

binding  site:  a  major  shift  in  ligand  specificity  through  modest  changes  in  architecture.  PLoS  
Pathog.  8,  e1002492  (2012).  
17.  

Bakkers,   M.   J.   G.   et   al.   Coronavirus   receptor   switch   explained   from   the  

stereochemistry  of  protein-­carbohydrate  interactions  and  a  single  mutation.  Proc.  Natl.  Acad.  
Sci.  U.S.A.  113,  E3111–9  (2016).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  
18.  

  

  

Woo,   P.   C.   Y.   et   al.   Characterization   and   complete   genome   sequence   of   a   novel  

coronavirus,  coronavirus  HKU1,  from  patients  with  pneumonia.  Journal  of  Virology  79,  884–
895  (2005).  
19.  

Kühlbrandt,   W.   Biochemistry.   The   resolution   revolution.   Science   343,   1443–1444  

(2014).  
20.  

Tortorici,  M.  A.  et  al.  Structural  basis  for  human  coronavirus  attachment  to  sialic  acid  

receptors.  Nat.  Struct.  Mol.  Biol.  26,  481–489  (2019).  
21.  

Kirchdoerfer,  R.  N.  et  al.  Pre-­fusion  structure  of  a  human  coronavirus  spike  protein.  

Nature  531,  118–121  (2016).  
22.  

Khoshouei,   M.,   Radjainia,   M.,   Baumeister,   W.   &   Danev,   R.   Cryo-­EM   structure   of  

haemoglobin  at  3.2  Å  determined  with  the  Volta  phase  plate.  Nat  Commun  8,  16099–6  (2017).  
23.  

Herzik,  M.  A.,  Wu,  M.  &  Lander,  G.  C.  High-­resolution  structure  determination  of  sub-­

100  kDa  complexes  using  conventional  cryo-­EM.  Nat  Commun  10,  1032–9  (2019).  
24.  

Fan,   X.   et   al.   Single   particle   cryo-­EM   reconstruction   of   52  kDa   streptavidin   at   3.2  

Angstrom  resolution.  Nat  Commun  10,  2386–11  (2019).  
25.  

Woo,  P.  C.  Y.  et  al.  Comparative  analysis  of  22  coronavirus  HKU1  genomes  reveals  a  

novel   genotype   and   evidence   of   natural   recombination   in   coronavirus   HKU1.   Journal   of  
Virology  80,  7136–7145  (2006).  
26.  

Narimatsu,  Y.  et  al.  An  Atlas  of  Human  Glycosylation  Pathways  Enables  Display  of  the  

Human  Glycome  by  Gene  Engineered  Cells.  Mol.  Cell  75,  394–407.e5  (2019).  
27.  

Deregt,  D.  &  Babiuk,  L.  A.  Monoclonal  antibodies  to  bovine  coronavirus:  characteristics  

and  topographical  mapping  of  neutralizing  epitopes  on  the  E2  and  E3  glycoproteins.  Virology  
161,  410–420  (1987).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  
28.  

  

  

Milane,  G.,  Kourtesis,  A.  B.  &  Dea,  S.  Characterization  of  monoclonal  antibodies  to  the  

hemagglutinin-­esterase  glycoprotein  of  a  bovine  coronavirus  associated  with  winter  dysentery  
and  cross-­reactivity  to  field  isolates.  J.  Clin.  Microbiol.  35,  33–40  (1997).  
29.  

Desforges,  M.,  Desjardins,  J.,  Zhang,  C.  &  Talbot,  P.  J.  The  acetyl-­esterase  activity  of  

the   hemagglutinin-­esterase   protein   of   human   coronavirus   OC43   strongly   enhances   the  
production  of  infectious  virus.  Journal  of  Virology  87,  3097–3107  (2013).  
30.  

Deregt,   D.  et   al.   Monoclonal  antibodies   to   bovine   coronavirus   glycoproteins  E2   and  

E3:  demonstration  of  in  vivo  virus-­neutralizing  activity.  Journal  of  General  Virology  70  (  Pt  4),  
993–998  (1989).  
31.  

Al-­Khannaq,  M.  N.  et  al.  Molecular  epidemiology  and  evolutionary  histories  of  human  

coronavirus  OC43  and  HKU1  among  patients  with  upper  respiratory  tract  infections  in  Kuala  
Lumpur,  Malaysia.  Virol.  J.  13,  33–12  (2016).  
32.  

Yang,  H.,  Chen,  L.-­M.,  Carney,  P.  J.,  Donis,  R.  O.  &  Stevens,  J.  Structures  of  receptor  

complexes   of   a   North   American   H7N2   influenza   hemagglutinin   with   a   loop   deletion   in   the  
receptor  binding  site.  PLoS  Pathog.  6,  e1001081  (2010).  
33.  

Peacock,  T.  P.  et  al.  Immune  Escape  Variants  of  H9N2  Influenza  Viruses  Containing  

Deletions   at   the   Hemagglutinin   Receptor   Binding   Site   Retain   Fitness   In   Vivo   and   Display  
Enhanced  Zoonotic  Characteristics.  Journal  of  Virology  91,  8413  (2017).  
34.  

Saunders,   C.  J.  et   al.   The   V1,  V2,  and  V3   regions  of   the  human   immunodeficiency  

virus  type  1  envelope  differentially  affect  the  viral  phenotype  in  an  isolate-­dependent  manner.  
Journal  of  Virology  79,  9069–9080  (2005).  
35.  

Zivanov,   J.   et   al.   New   tools   for   automated   high-­resolution   cryo-­EM   structure  

determination  in  RELION-­3.  Elife  7,  163  (2018).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  
36.  

  

  

Zheng,   S.   Q.   et   al.   MotionCor2:   anisotropic   correction   of   beam-­induced   motion   for  

improved  cryo-­electron  microscopy.  Nat.  Methods  14,  331–332  (2017).  
37.  

Zhang,   K.   Gctf:   Real-­time   CTF   determination   and   correction.   Journal   of   Structural  

Biology  193,  1–12  (2016).  
38.  

Pettersen,  E.  F.  et  al.  UCSF  Chimera-­-­a  visualization  system  for  exploratory  research  

and  analysis.  J  Comput  Chem  25,  1605–1612  (2004).  
39.  

Zivanov,  J.,  Nakane,  T.  &  Scheres,  S.  H.  W.  A  Bayesian  approach  to  beam-­induced  

motion  correction  in  cryo-­EM  single-­particle  analysis.  IUCrJ  6,  5–17  (2019).  
40.  

Zivanov,  J.,  Nakane,  T.  &  Scheres,  S.  H.  W.  Estimation  of  high-­order  aberrations  and  

anisotropic  magnification  from  cryo-­EM  data  sets  in  RELION-­3.1.  IUCrJ  7,  253–267  (2020).  
41.  

Kelley,  L.  A.,  Mezulis,  S.,  Yates,  C.  M.,  Wass,  M.  N.  &  Sternberg,  M.  J.  E.  The  Phyre2  

web  portal  for  protein  modeling,  prediction  and  analysis.  Nat  Protoc  10,  845–858  (2015).  
42.  

Emsley,   P.   &   Cowtan,   K.   Coot:   model-­building   tools   for   molecular   graphics.   Acta  

Crystallogr.  D  Biol.  Crystallogr.  60,  2126–2132  (2004).  
43.  

Emsley,  P.  &  Crispin,  M.  Structural  analysis  of  glycoproteins:  building  N-­linked  glycans  

with  Coot.  Acta  Crystallogr  D  Struct  Biol  74,  256–263  (2018).  
44.  

Headd,   J.   J.   et   al.   Use   of   knowledge-­based   restraints   in   phenix.refineto   improve  

macromolecular  refinement  at  low  resolution.  Acta  Crystallogr.  D  Biol.  Crystallogr.  68,  381–
390  (2012).  
45.  

Chen,   V.   B.   et   al.   MolProbity:   all-­atom   structure   validation   for   macromolecular  

crystallography.  Acta  Crystallogr.  D  Biol.  Crystallogr.  66,  12–21  (2010).  

  
  

  

  

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.998963; this version posted March 26, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY 4.0 International license.

  
  
46.  

  

  

Agirre,  J.  et  al.  Privateer:  software  for  the  conformational  validation  of  carbohydrate  

structures.  Nat.  Struct.  Mol.  Biol.  22,  833–834  (2015).  
47.  

Agirre,  J.,  Davies,  G.,  Wilson,  K.  &  Cowtan,  K.  Carbohydrate  anomalies  in  the  PDB.  

Nat.  Chem.  Biol.  11,  303–303  (2015).  
48.  

Madeira,  F.  et  al.  The  EMBL-­EBI  search  and  sequence  analysis  tools  APIs  in  2019.  

Nucleic  Acids  Res.  47,  W636–W641  (2019).  
49.  

Goddard,  T.  D.  et  al.  UCSF  ChimeraX:  Meeting  modern  challenges  in  visualization  and  

analysis.  Protein  Sci.  27,  14–25  (2018).  
50.  

Frese,   C.   K.   et   al.   Unambiguous   phosphosite   localization   using   electron-­

transfer/higher-­energy   collision   dissociation   (EThcD).   J.   Proteome   Res.   12,   1520–1525  
(2013).  
51.  

Bern,  M.,  Kil,  Y.  J.  &  Becker,  C.  Byonic:  advanced  peptide  and  protein  identification  

software.  Curr  Protoc  Bioinformatics  Chapter  13,  Unit13.20  (2012).  
52.  

MacLean,  B.  et  al.  Skyline:  an  open  source  document  editor  for  creating  and  analyzing  

targeted  proteomics  experiments.  Bioinformatics  26,  966–968  (2010).  

  
  

  

  

